Browse articles on EyeWorld.org from the Cornea section. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Three physicians discussed the recent uptick in primary graft failures, the data, and the potential culprit.
Punctal occlusion remains an important resource to help dry eye patients. Several ophthalmologists shared how they use punctal occlusion in practice, available options, and a new product in this space.
When planning cataract surgery, it’s important to pay particular attention to patients who may have a compromised cornea or endothelial damage. Two cornea specialists spoke with EyeWorld about considerations for cataract surgery in these eyes.
The learning curve for DMEK is steep, but most training opportunities are reserved for those in a cornea fellowship. Objective data on the efficiency of wet labs, which don’t pose a risk to patients, don’t waste valuable tissue, and are available to those at earlier skill levels, was recently published.
There are several options for antiviral treatments for HSV, and in this article, two ophthalmologists spoke about the topical and oral options, when to get patients treated, how quickly the treatment works, and how this can impact patients in the future.
For years, ophthalmologists had limited prescription options for patients with ocular surface disease. In the last decade, the number of available options has grown with several receiving approval in 2023. Two experts shared their thoughts and experiences with these new options.
“As we continue to see progress in ocular surface therapeutics, we need to continue to evolve our vocabulary surrounding ocular surface disease. I challenge you to start differentiating your ‘dry eye’ patients as you see them in clinic,” said Cornea Editor Julie Schallhorn, MD. Read her introduction to the Cornea section for more details.
Who are the best patients? What are the outcomes like? What’s in store for the future? Three physicians answered these questions and more as they pertain to platelet-derived ocular surface therapies, giving insights on what they wish ophthalmologists knew about these products.
Two physicians detailed Ocular Surface Stem Cell Transplantation with Systemic Immunosuppression for the treatment of severe ocular surface disease with limbal stem cell deficiency and obstacles to its adoption among corneal surgeons.
The articles in the Cornea section represent a challenge to corneal specialists to develop the centers necessary to treat complex conditions or refer patients to providers who have. “Reading them made me feel a renewed energy and commitment to patient care, and I hope you feel the same,” said Cornea Editor Julie Schallhorn, MD.
Get the latest ophthalmology news delivered to your inbox every Friday.